14 Oct 2025

"Caracol Secures $40 Million Series B Funding Round Led by Omnes Capital and Move Capital"

"Caracol has successfully closed a $40 million Series B funding round, co-led by Omnes Capital and Move Capital Fund I, with participation from CDP Venture Capital, Primo Capital SGR, Eureka! Venture SGR, and Neva SGR. Various law firms provided legal assistance to the involved parties, while Growth Capital acted as the financial advisor for Caracol during the transaction."

**Press Release Summary:** Several law firms participated in a recent transaction involving Caracol, including Legance, Fieldfisher, TARGET, and Portolano Cavallo. Legance assisted CDP Venture Capital SGR, Move Capital Fund I, and Omnes Capital; Fieldfisher represented Caracol; TARGET supported Primo Capital SGR and Eureka! Venture SGR; and Portolano Cavallo advised Neva SGR. Caracol successfully closed a Series B funding round amounting to $40 million, co-led by Omnes Capital and Move Capital Fund I, with participation from CDP Venture Capital – Large Ventures Fund, Primo Capital SGR, Eureka! Venture SGR, and Neva SGR (the venture capital company of the Intesa Sanpaolo Group). The legal teams involved in the transaction included: - **Legance**: - Andrea Fedi (Senior Lawyer) - Paolo Guaragnella (Senior Lawyer) - Giorgio Abbadessa (Senior Lawyer) - Federica Favilla (Senior Lawyer) - **Fieldfisher**: - Niccolò Massimo Gruppi (Partner) - Filippo Attanasio (Senior Associate) - Lorenzo Gherardi (Junior Associate) - **TARGET**: - Roberto Nigro (Partner) - Sveva Ricci (Managing Associate) - Sara Aratari (Senior Associate) - **Portolano Cavallo**: - Alessandro Tanno (Partner) - Daniel Joseph Giuliano (Senior Associate) Additionally, the notarial aspects of the transaction were handled by notaries Giovanni Ricci and Davide Micella, along with lawyer Chiara Nicolò from the Ricci e Radaelli – Notai Associati firm. Growth Capital acted as the financial advisor to Caracol for the structuring, negotiation, and execution of the deal.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.